Intention tremor refers to the rhythmic and involuntary contraction and relaxation of muscles with movement toward a target, which is a common sequela of multiple sclerosis and usually occurs in the distal joints of the upper limb. Functional electrical stimulation (FES) is feasible for tremor suppression because of its fewer side effects, low cost, and portability. Most existing FES-based design methods assume that tremor is a single-frequency signal, though it is multifrequency in reality. The idealized simplification will limit the performance of tremor suppression. To address the problem, this article proposes an FES-based multiperiodic repetitive control (MP-RC) scheme to suppress multiple frequency wrist tremors. First, a nonlinear wrist musculoskeletal model with a Hammerstein structure is established. Then, a control strategy combining the model inverse linearization control and MP-RC is proposed for tremor suppression. A frequency-modified inverse RC algorithm and a gradient-based RC algorithm are developed to regulate the FES level. Finally, comparative experiments on four unimpaired participants and an intention tremor patient are conducted to validate the effectiveness of the proposed control schemes. Experimental results show that the MP-RC scheme can suppress tremors by up to 90.52%. Compared with the traditional filter-based feedback controller and the single-periodic repetitive controller, the proposed multiperiodic repetitive controller can achieve an average of 26% and 16% improvement, respectively, in tremor suppression, demonstrating the advantages of the proposed design.
30 October 2024 in Frontiers in Human Neuroscience
Background: Although the application of brain-computer interface (BCI) technology in rehabilitation has been extensively studied, a systematic and comprehensive bibliometric analysis of this area remains lacking. Thus, this study aims to analyze the research progress of BCI technology in rehabilitation through bibliometric methods.Methods: The study retrieved relevant publications on BCI technology in rehabilitation from the Web of Science Core Collection (WoSCC) between January 1, 2004, and June 30, 2024. The search was conducted using thematic queries, and the document types included “original articles” and “review articles.” Bibliometric analysis and knowledge mapping were performed using the Bibliometrix package in R software and CiteSpace software.Results: During the study period, a total of 1,431 publications on BCI technology in rehabilitation were published by 4,932 authors from 1,281 institutions across 79 countries in 386 academic journals. The volume of research literature in this field has shown a steady upward trend. The United States of America (USA) and China are the primary contributors, with Eberhard Karls University of Tübingen being the most active research institution. The journal Frontiers in Neuroscience published the most articles, while the Journal of Neural Engineering was the most cited. Niels Birbaumer not only authored the most articles but also received the highest number of citations. The main research areas include neurology, sports medicine, and ophthalmology. The diverse applications of BCI technology in stroke and spinal cord injury rehabilitation, as well as the evaluation of BCI performance, are current research hotspots. Moreover, deep learning has demonstrated significant potential in BCI technology rehabilitation applications.Conclusion: This bibliometric study provides an overview of the research landscape and developmental trends of BCI technology in rehabilitation, offering valuable reference points for researchers in formulating future research strategies.
Vascular cognitive impairment (VCI), a prevalent form of dementia resulting from chronic cerebral hypoperfusion (CCH), remains devoid of effective therapeutic strategies. While hyperbaric oxygen therapy (HBOT) has shown promise in mitigating neurological damage, its molecular mechanisms remain incompletely elucidated. Here, we demonstrate that HBOT confers robust neuroprotection against CCH-induced VCI through the microRNA-137-3p (miR-137-3p)/TNF receptor-associated factor 3 (TRAF3) signaling axis. In a mouse model of CCH, prolonged HBOT administration significantly improved cognitive performance across multiple behavioral domains—including spatial, recognition, and contextual memory—concomitant with enhanced cerebral blood flow and oxygen saturation. Mechanistically, HBOT upregulated hippocampal miR-137-3p, which directly targeted TRAF3, leading to suppression of the TAK1/NF-κB pathway and attenuation of neuroinflammation and neuronal apoptosis. Using neuron–astrocyte–microglia tri-culture systems, we established that miR-137-3p agonism recapitulated HBOT-mediated neuroprotection, whereas TRAF3 overexpression exacerbated inflammatory and apoptotic cascades. Our findings identify the miR-137-3p/TRAF3/NF-κB pathway as a critical effector of HBOT efficacy, offering a promising therapeutic target for vascular cognitive impairment.